Pharmacogenomics of coumarin anticoagulants: Are we underestimating the role of CYP2C9?
Tom Schalekamp, Anke-Hilse Maitland – van der Zee, Anthonius de Boer
Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands
DOI
http://dx.doi.org/10.1160/TH08-07-0425